Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



ELI LILLY AND COMPANY Hits Forecast Price Target with 36.42% Profit, Confirming QuantWave's Accuracy

August 08, 2023
ELI LILLY AND COMPANY has recently achieved its forecast price target as predicted by QuantWave on April 24, 2023. The forecast indicated a long position with the stock priced at $376.94 at the time of the signal. On August 8, 2023, ELI LILLY AND COMPANY reached the target price of $514.21, resulting in a substantial profit of 36.42% for investors following the forecast.

This success demonstrates the accuracy and reliability of QuantWave's forecasting capabilities, providing valuable insights for investors navigating the financial markets. The achievement of the price target for ELI LILLY AND COMPANY highlights the effectiveness of QuantWave's analytics in predicting stock movements and identifying profitable opportunities.

In the broader context of QuantWave's platform, this accomplishment reinforces the platform's reputation as a leading automated forecasting system. With a track record of accurate predictions and profitable outcomes, QuantWave offers users access to forecasts for a wide range of stocks, presenting potential opportunities for investors to capitalize on market trends and generate returns.

For those seeking to deepen their understanding of QuantWave's investment strategy, QuantSchool offers comprehensive educational resources designed to enhance investors' proficiency in utilizing the forecasting system. QuantSchool provides essential insights into the key principles for leveraging the QuantWave platform effectively, empowering users to generate consistent income through informed investment decisions.
If you want to leave a comment, then you need Login or Register





Other data for LLY

Related data

LLYJuly 20, 2025Strong Q2 Forecast for ELI LILLY AND COMPANY by J.P. Morgan  ~1 min.

According to J.P. Morgan, Eli Lilly and Company is expected to have a strong second quarter performance. The pharmaceutical giant has been receiving positive attention from investors and analysts alike....

LLYMarch 22, 2025Eli Lilly and Company LLY: Leading the Way in Pharmaceutical Innovation  ~2 min.

Eli Lilly and Company (LLY) continues to make waves in the pharmaceutical industry with its innovative and groundbreaking therapies....

LLYMarch 19, 2025Eli Lilly and Company LLY Surges After Breakthrough BRAVE-AA-PEDS Study Results  ~2 min.

Eli Lilly and Company (LLY) has recently made a significant breakthrough in its BRAVE-AA-PEDS study, resulting in a surge of investor attention and market gains....

LLYMarch 18, 2025Eli Lilly and Company: A Promising Investment in the Pharma Industry  ~1 min.

Eli Lilly and Company (LLY) has been making waves in the pharmaceutical industry with its innovative products and strong performance....

LLYMarch 17, 2025Eli Lilly and Company's Groundbreaking Discovery Revolutionizes Pharma Industry  ~2 min.

Eli Lilly and Company, a renowned pharmaceutical giant, has recently made a groundbreaking discovery that is set to revolutionize the entire industry....

LLYMarch 16, 2025Is Eli Lilly and Company LLY Set to Revolutionize the Pharma Industry?  ~2 min.

Eli Lilly and Company (LLY) has been making headlines recently with its groundbreaking research and innovative products....

LLYMarch 14, 2025Eli Lilly and Company Reports Promising Results in Hair Regrowth Study  ~1 min.

Eli Lilly and Company (LLY) recently announced the positive outcome of their Phase 3 clinical trial for baricitinib, a drug aimed at treating severe alopecia areata in adolescents....

LLYFebruary 28, 2025Lilly plans to more than double U.S. manufacturing investment since 2020 exceeding 50 billion  ~1 min.

Eli Lilly and Company (LLY) is set to significantly increase its manufacturing investment in the United States, surpassing a staggering 50 billion since 2020....

LLYFebruary 27, 2025Eli Lilly and Company Acquires Organovos FXR Program in IBD Treatment Development  ~1 min.

Eli Lilly and Company has recently made headlines with its acquisition of Organovos FXR Program, a significant step towards advancing treatment options for Inflammatory Bowel Disease (IBD)....

LLYFebruary 26, 2025ELI LILLY AND COMPANY Launches Additional Zepbound Vial Doses and Offers New Savings  ~2 min.

ELI LILLY AND COMPANY has recently announced the launch of additional Zepbound vial doses, as well as new savings for self-pay patients....

CRMDecember 18, 2023SALESFORCE, INC. Stock Hits QuantWave's Price Target Forecast with 22.2% Profit  ~1 min.

SALESFORCE, INC. (CRM) investors rejoiced as QuantWave's forecast signal successfully reached its price target, delivering a substantial 22.2% profit....

NVDAMay 25, 2023QuantWave Successfully Achieves 40.66% Profit Target Forecast for NVIDIA CORPORATION Stock  ~1 min.

QuantWave, the automated forecasting platform, has recently accomplished a significant milestone by accurately predicting a price target for NVIDIA CORPORATION stock with a profit margin of 40.66%....

ETH-USDJuly 16, 2025QuantWave Achieves 29.24% Profit Target Forecast for ETHEREUM USD  ~1 min.

QuantWave, the automated forecasting platform, has successfully hit a price target forecast for the stock ETHEREUM USD, resulting in a profit of 29.24%....

DHRApril 1, 2025QuantWave Successfully Achieves 14.46% Profit Target Forecast for Danaher Corporation  ~2 min.

QuantWave, the automated forecasting platform, recently celebrated a significant milestone as it successfully achieved a forecasted profit target of 14.46% for the stock of Danaher Corporation....

KOApril 22, 2025QuantWave Successfully Achieves 25.74% Profit in THE COCA-COLA COMPANY Stock Forecast  ~1 min.

QuantWave, the automated forecasting platform, has marked a significant achievement with the successful price target forecast for THE COCA-COLA COMPANY stock....